The value of PRECISE-DAPT score and lesion complexity for predicting all-cause mortality in patients with NSTEMI

The Egyptian Heart Journal

Table 1 Demographic and laboratory parameters of the study population

Variable	All (n = 343)	Non-survivor (n = 31)	Survivor (n = 312)	p-value*
Age (year), mean ± SD	63.5 ± 11.8	69.6 ± 13.2	62.9 ± 11.5	0.003
Male gender, n (%)	217 (63.3)	24 (77.4)	193 (61.9)	0.087
Previous medical history
HT, n (%)	182 (53.1)	14 (45.2)	168 (53.8)	0.355
CAD n (%)	34 (9.9)	2 (6.5)	32 (10.3)	0.499
DM, n (%)	83 (24.2)	13 (41.9)	70 (22.4)	0.016
Previous stroke/TIA, n (%)	19 (5.5)	1 (3.2)	18 (5.8)	0.555
Smoking, n (%)	100 (29.2)	7 (22.6)	93 (29.8)	0.398
Laboratory parameters
hs-CRP	0.5 (1.4)	1.9 (5.7)	0.5(1.0)	0.069
Hgb (g/dl), mean ± SD	12.9 ± 1.9	11.6 ± 1.8	13.1 ± 1.8	< 0.001
WBC (nmol/L), mean ± SD	11.2 ± 7.0	12.3 ± 5.5	11.1 ± 7.2	0.346
eGFR, mean ± SD	100.3 ± 36.7	77.9 ± 40.9	102.5 ± 35.6	< 0.001
hs-cTnT-I, pg/mL, median, [IQR]	0.74 (5.9)	2.6 (12.1)	0.7 (4.9)	0.004
Platelet count, × 10³/uL	264.2 ± 73.6	252.8 ± 77.6	265.7 ± 73.1	0.377
Scores
CHADS₂, mean ± SD	1.3 ± 1.0	1.6 ± 0.8	1.3 ± 1.0	0.109
CHA₂DS₂-VASc, mean ± SD	2.2 ± 1.5	2.5 ± 1.3	2.2 ± 1.5	0.283
ATRIA, mean ± SD	3.1 ± 2.4	4.5 ± 2.8	3.0 ± 2.3	0.002
R₂CHA₂DS₂-VASc, mean ± SD	3.2 ± 1.8	3.7 ± 1.7	3.1 ± 1.7	0.073
SX, mean ± SD	13.3 ± 8.2	20.6 ± 11.3	12.5 ± 7.5	< 0.001
PRECISE-DAPT, mean ± SD	13.1 ± 11.4	22.0 ± 14.5	12.0 ± 10.6	< 0.001

*p value was calculated using an independent samples t test or the Mann–Whitney U-test for continuous variables and a chi-squared test or the Fisher’s exact test for categorical variables, as appropriate. *p value < 0.05 was considered significant
Abbreviations: CAD, coronary artery disease; DM, diabetes mellitus; hs-cTnT-I, high-sensitivity cardiac troponin-I; Hgb, hemoglobin; hs-CRP, high-sensitivity C-reactive protein; HT, hypertension; SX, SYNTAX score; WBC, white blood cell. Values are n (%), median (interquartile range [IQR]), or mean ± standard deviation
p value < 0.05 was considered significant